XML 84 R73.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 16 - Condensed Consolidating Financial Information of Guarantor Subsidiaries - Condensed Consolidating Cash Flow Information (Details) - USD ($)
$ in Thousands
9 Months Ended
Feb. 28, 2017
Feb. 29, 2016
Net cash (used in) provided by operating activities $ (6,499) $ 6,841
Net cash used in investing activities (8,318) (12,650)
Net cash provided by (used in) financing activities 14,498 (482)
Effect of exchange rate changes on cash and cash equivalents 91 118
Increase (decrease) in cash and cash equivalents (228) (6,173)
Cash and cash equivalents at beginning of period 10,263 18,363
Cash and cash equivalents at end of period 10,035 12,190
Reportable Legal Entities [Member] | Parent Company [Member]    
Net cash (used in) provided by operating activities (5,034) 10,666
Net cash used in investing activities (2,414) (8,860)
Net cash provided by (used in) financing activities 7,345 (6,475)
Effect of exchange rate changes on cash and cash equivalents 140 269
Increase (decrease) in cash and cash equivalents 37 (4,400)
Cash and cash equivalents at beginning of period 4,058 7,080
Cash and cash equivalents at end of period 4,095 2,680
Reportable Legal Entities [Member] | Guarantor Subsidiaries [Member]    
Net cash (used in) provided by operating activities 1,337 1,423
Net cash used in investing activities (1,196) (1,671)
Net cash provided by (used in) financing activities (147) (7)
Effect of exchange rate changes on cash and cash equivalents
Increase (decrease) in cash and cash equivalents (6) (255)
Cash and cash equivalents at beginning of period (187) (263)
Cash and cash equivalents at end of period (193) (518)
Reportable Legal Entities [Member] | Non-Guarantor Subsidiaries [Member]    
Net cash (used in) provided by operating activities 9,187 (1,600)
Net cash used in investing activities (663) 3,890
Net cash provided by (used in) financing activities (8,744) (3,517)
Effect of exchange rate changes on cash and cash equivalents (340) (291)
Increase (decrease) in cash and cash equivalents (560) (1,518)
Cash and cash equivalents at beginning of period 6,356 11,546
Cash and cash equivalents at end of period 5,796 10,028
Reportable Legal Entities [Member] | Immucor Inc and Subsidiaries [Member]    
Net cash (used in) provided by operating activities 358  
Net cash used in investing activities (8,176)  
Net cash provided by (used in) financing activities 7,198  
Effect of exchange rate changes on cash and cash equivalents 91  
Increase (decrease) in cash and cash equivalents (529)  
Cash and cash equivalents at beginning of period 10,227  
Cash and cash equivalents at end of period 9,698  
Reportable Legal Entities [Member] | VIE and VIE Eliminations [Member]    
Net cash (used in) provided by operating activities (6,857)  
Net cash used in investing activities (142)  
Net cash provided by (used in) financing activities 7,300  
Effect of exchange rate changes on cash and cash equivalents  
Increase (decrease) in cash and cash equivalents 301  
Cash and cash equivalents at beginning of period 36  
Cash and cash equivalents at end of period 337  
Consolidation, Eliminations [Member]    
Net cash (used in) provided by operating activities (5,132) (3,648)
Net cash used in investing activities (3,903) (6,009)
Net cash provided by (used in) financing activities 8,744 9,517
Effect of exchange rate changes on cash and cash equivalents 291 140
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period